帕洛克西斯马尔Kinesigenic Dyskinesia:遗传学和病理生理机制
Jiao-Jiao Xu1,2, Hong-Fu Li1,2, Zhi-Ying Wu3,4
1Department of Medical Genetics and Center for Rare Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Neuroscience bulletin
|December 13, 2023
概括
松性中国性运动障碍症 (PKD) 涉及由于基因突变而导致的突然运动. 研究表明,PKD可能源于离子通道或突触问题,特别是在小脑.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 运动障碍 运动障碍
背景情况:
- 松发作性中国性运动障碍 (PKD) 是一种常见的松发作性运动障碍.
- 它的特点是短暂的,非自愿的choreoathetoid或 dystonic运动,由自愿的行动触发.
- 主要与PRRT2和TMEM151A基因的突变有关.
研究的目的:
- 阐明PKD不清楚的病理生理机制.
- 研究PRRT2蛋白功能在PKD中的作用.
- 探索PKD作为通道病变或突触病变的潜力.
主要方法:
- 对PKD遗传学和病理生理学现有文献的综述.
- 分析PRRT2蛋白功能及其影响.
- 检查小脑的作用和大脑的潜在参与.
主要成果:
- 人们对PRRT2蛋白的功能知之甚远.
- PKD的发病可能涉及异常的离子通道和突触传输中断.
- 小脑被确定为一个关键的致病区域,与发作相关的脱极化传播.
结论:
- PKD可能被分类为通道病变,突触病变,或两者兼而有之.
- 需要进一步研究大脑 (皮质,丘脑) 在PKD中的作用,超出小脑.
相关概念视频
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
677
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
677
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Disorders of the Skeletal Muscle
962
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
962
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
336
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
336


